vs
Fastly, Inc.（FSLY）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Fastly, Inc.的季度营收约是再鼎医药的1.4倍（$173.0M vs $127.1M），Fastly, Inc.同比增速更快（19.8% vs 17.1%），Fastly, Inc.自由现金流更多（$4.1M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 14.3%）
Fastly是总部位于美国旧金山的云计算服务商，主营内容分发网络（CDN）、图片优化、负载均衡服务，同时提供DDoS攻击防护、机器人流量治理、Web应用防火墙等云安全解决方案，助力企业提升网络访问效率与安全防护能力。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
FSLY vs ZLAB — 直观对比
营收规模更大
FSLY
是对方的1.4倍
$127.1M
营收增速更快
FSLY
高出2.6%
17.1%
自由现金流更多
FSLY
多$30.8M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
14.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $173.0M | $127.1M |
| 净利润 | $-20.5M | — |
| 毛利率 | 62.5% | 51.0% |
| 营业利润率 | 23.7% | -54.6% |
| 净利率 | -11.9% | — |
| 营收同比 | 19.8% | 17.1% |
| 净利润同比 | 47.6% | — |
| 每股收益（稀释后） | $-0.13 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSLYZLAB
| Q1 26 | $173.0M | — | ||
| Q4 25 | $172.6M | $127.1M | ||
| Q3 25 | $158.2M | $115.4M | ||
| Q2 25 | $148.7M | $109.1M | ||
| Q1 25 | $144.5M | $105.7M | ||
| Q4 24 | $140.6M | $108.5M | ||
| Q3 24 | $137.2M | $101.8M | ||
| Q2 24 | $132.4M | $100.1M |
净利润FSLYZLAB
| Q1 26 | $-20.5M | — | ||
| Q4 25 | $-15.5M | — | ||
| Q3 25 | $-29.5M | $-36.0M | ||
| Q2 25 | $-37.5M | $-40.7M | ||
| Q1 25 | $-39.1M | $-48.4M | ||
| Q4 24 | $-32.9M | — | ||
| Q3 24 | $-38.0M | $-41.7M | ||
| Q2 24 | $-43.7M | $-80.3M |
毛利率FSLYZLAB
| Q1 26 | 62.5% | — | ||
| Q4 25 | 61.4% | 51.0% | ||
| Q3 25 | 58.4% | 59.5% | ||
| Q2 25 | 54.5% | 60.6% | ||
| Q1 25 | 53.2% | 63.6% | ||
| Q4 24 | 53.4% | 61.5% | ||
| Q3 24 | 54.5% | 64.1% | ||
| Q2 24 | 55.1% | 64.9% |
营业利润率FSLYZLAB
| Q1 26 | 23.7% | — | ||
| Q4 25 | -8.7% | -54.6% | ||
| Q3 25 | -18.2% | -42.3% | ||
| Q2 25 | -24.8% | -50.3% | ||
| Q1 25 | -26.4% | -53.3% | ||
| Q4 24 | -24.4% | -62.6% | ||
| Q3 24 | -29.6% | -66.6% | ||
| Q2 24 | -35.3% | -76.0% |
净利率FSLYZLAB
| Q1 26 | -11.9% | — | ||
| Q4 25 | -9.0% | — | ||
| Q3 25 | -18.6% | -31.2% | ||
| Q2 25 | -25.2% | -37.3% | ||
| Q1 25 | -27.1% | -45.8% | ||
| Q4 24 | -23.4% | — | ||
| Q3 24 | -27.7% | -40.9% | ||
| Q2 24 | -33.0% | -80.2% |
每股收益（稀释后）FSLYZLAB
| Q1 26 | $-0.13 | — | ||
| Q4 25 | $-0.10 | $-0.05 | ||
| Q3 25 | $-0.20 | $-0.03 | ||
| Q2 25 | $-0.26 | $-0.04 | ||
| Q1 25 | $-0.27 | $-0.04 | ||
| Q4 24 | $-0.23 | $-0.09 | ||
| Q3 24 | $-0.27 | $-0.04 | ||
| Q2 24 | $-0.32 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.7M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $977.1M | $715.5M |
| 总资产 | $1.5B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FSLYZLAB
| Q1 26 | $146.7M | — | ||
| Q4 25 | $361.8M | $689.6M | ||
| Q3 25 | $342.9M | $717.2M | ||
| Q2 25 | $321.2M | $732.2M | ||
| Q1 25 | $307.3M | $757.3M | ||
| Q4 24 | $295.9M | $779.7M | ||
| Q3 24 | $308.2M | $616.1M | ||
| Q2 24 | $311.8M | $630.0M |
股东权益FSLYZLAB
| Q1 26 | $977.1M | — | ||
| Q4 25 | $929.6M | $715.5M | ||
| Q3 25 | $937.0M | $759.9M | ||
| Q2 25 | $942.6M | $791.7M | ||
| Q1 25 | $957.0M | $810.8M | ||
| Q4 24 | $965.3M | $840.9M | ||
| Q3 24 | $969.5M | $667.7M | ||
| Q2 24 | $981.2M | $704.2M |
总资产FSLYZLAB
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.5B | $1.2B | ||
| Q3 24 | $1.5B | $985.3M | ||
| Q2 24 | $1.5B | $987.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $4.1M | $-26.7M |
| 自由现金流率自由现金流/营收 | 2.4% | -21.0% |
| 资本支出强度资本支出/营收 | 14.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $55.2M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流FSLYZLAB
| Q1 26 | $28.9M | — | ||
| Q4 25 | $22.4M | $-26.0M | ||
| Q3 25 | $28.9M | $-32.0M | ||
| Q2 25 | $25.8M | $-31.0M | ||
| Q1 25 | $17.3M | $-61.7M | ||
| Q4 24 | $5.2M | $-55.8M | ||
| Q3 24 | $5.0M | $-26.8M | ||
| Q2 24 | $-4.9M | $-42.2M |
自由现金流FSLYZLAB
| Q1 26 | $4.1M | — | ||
| Q4 25 | $12.2M | $-26.7M | ||
| Q3 25 | $22.9M | $-35.0M | ||
| Q2 25 | $15.9M | $-33.9M | ||
| Q1 25 | $14.7M | $-63.2M | ||
| Q4 24 | $251.0K | $-58.4M | ||
| Q3 24 | $3.0M | $-28.2M | ||
| Q2 24 | $-6.7M | $-42.9M |
自由现金流率FSLYZLAB
| Q1 26 | 2.4% | — | ||
| Q4 25 | 7.1% | -21.0% | ||
| Q3 25 | 14.5% | -30.4% | ||
| Q2 25 | 10.7% | -31.1% | ||
| Q1 25 | 10.2% | -59.9% | ||
| Q4 24 | 0.2% | -53.8% | ||
| Q3 24 | 2.2% | -27.7% | ||
| Q2 24 | -5.1% | -42.9% |
资本支出强度FSLYZLAB
| Q1 26 | 14.3% | — | ||
| Q4 25 | 5.9% | 0.5% | ||
| Q3 25 | 3.8% | 2.6% | ||
| Q2 25 | 6.6% | 2.6% | ||
| Q1 25 | 1.8% | 1.5% | ||
| Q4 24 | 3.5% | 2.4% | ||
| Q3 24 | 1.5% | 1.3% | ||
| Q2 24 | 1.3% | 0.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSLY
| Network Services | $126.2M | 73% |
| Security | $38.8M | 22% |
| Other | $8.0M | 5% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
